Pharmacokinetics and Clinical Effectiveness of Methylphenidate

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Clinical Pharmacokinetics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/00003088-199937060-00002PMID 10628897
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Behavior in Hyperactive Children Dose-Response Effects of Methylphenidate on Academic Performance and Overt

  2011cited by this paper
• Enantioselective Pharmacokinetics of dl-threo-Methylphenidate in Humans

  2004cited by this paper
• Nonlinear kinetics of threo-methylphenidate enantiomers in a patient with narcolepsy and in healthy volunteers

  2004cited by this paper
• Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?

  2000influential reference
• Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?

  1999cited by this paper
• Drug interactions with psychostimulants.

  1999cited by this paper
• Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction.

  1999cited by this paper
• Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration.

  1998cited by this paper
• National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices.

  1997cited by this paper
• Titrating methylphenidate in children with attention-deficit/hyperactivity disorder: is body mass predictive of clinical response?

  1997cited by this paper
• Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder.

  1997cited by this paper
• Pharmacokinetics and pharmacodynamics of methylphenidate enantiomers in rats

  1996cited by this paper
• Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain.

  1995cited by this paper
• Methylphenidate and cognitive flexibility: Dissociated dose effects in hyperactive children

  1995influential reference
• Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder.

  1995cited by this paper
• Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children.

  1994influential reference
• The utility of curriculum-based measurement for evaluating the effects of methylphenidate on academic performance.

  1994cited by this paper
• Pharmacokinetics and in vivo specificity of [LLC]dl‐threo‐methylphenidate for the presynaptic dopaminergic neuron

  1994influential reference
• Methylphenidate and cognitive perseveration in hyperactive children.

  1992cited by this paper
• Enantioselective pharmacokinetics and pharmacodynamics of dl‐thero‐mcthylphenidate in children with attention deficit hyperactivity disorder

  1992influential reference
• Stereoselective urinary pharmacokinetics of dl-threo-methylphenidate and its major metabolite in humans.

  1992cited by this paper
• Psychostimulant effects on learning and cognitive function: Findings and implications for children with Attention Deficit Hyperactivity Disorder

  1991influential reference
• Enantioselective gas chromatographic assay with electron-capture detection for dl-ritalinic acid in plasma.

  1990cited by this paper
• Kinetic analysis of enantiomers of threo-methylphenidate and its metabolite in two healthy subjects after oral administration as determined by a gas chromatographic-mass spectrometric method.

  1990cited by this paper
• Dose-dependent kinetics of methylphenidate enantiomers after oral administration of racemic methylphenidate to rats.

  1990cited by this paper
• Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation.

  1990cited by this paper
• Social judgment processes in hyperactive boys: Effects of methylphenidate and comparisons with normal peers

  1990cited by this paper
• Does methylphenidate constrict cognitive functioning?

  1989cited by this paper
• Enantioselective aspects of the disposition of dl-threo-methylphenidate after the administration of a sustained-release formulation to children with attention deficit-hyperactivity disorder.

  1989cited by this paper
• Sustained release methylphenidate: pharmacokinetic studies in ADDH males.

  1989cited by this paper
• The absorption of sustained‐release methylphenidate formulations compared to an immediate‐release formulation

  1989cited by this paper
• The free hormone hypothesis: a physiologically based mathematical model.

  1989cited by this paper
• Effects of methylphenidate on inhibitory control in hyperactive children

  1989influential reference
• Differential effects of methylphenidate and dextroamphetamine on the motor activity level of hyperactive children.

  1989cited by this paper
• Dose-response effects of methylphenidate on academic performance and overt behavior in hyperactive children.

  1989cited by this paper
• Attention deficit hyperactivity disorder and methylphenidate: the relationship between gross body weight and drug response in children.

  1989cited by this paper
• Attention deficit disorder and methylphenidate: a multilevel analysis of dose-response effects on children's impulsivity across settings.

  1988cited by this paper
• Effects of methylphenidate dosage in hyperactive reading-disabled children: I. Behavior and cognitive performance effects.

  1988cited by this paper
• Attention deficit disorder and methylphenidate: a multi-step analysis of dose-response effects on children's cardiovascular functioning.

  1988cited by this paper
• A survey of medication treatment for hyperactive/inattentive students.

  1988cited by this paper
• Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour

  1987cited by this paper
• Changes in family function and relationships in children who respond to methylphenidate.

  1987cited by this paper
• Stereoselective disposition of methylphenidate in children with attention-deficit disorder.

  1987cited by this paper
• Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder.

  1987cited by this paper
• Pharmacology of the enantiomers of threo-methylphenidate.

  1987cited by this paper
• Dependence and Independence in Responding to Double Stimulation : A Comparison of Stop , Change , and Dual-Task Paradigms

  1986cited by this paper
• Comparing classroom and clinic measures of attention deficit disorder: differential, idiosyncratic, and dose-response effects of methylphenidate.

  1986cited by this paper
• Methylphenidate in hyperactive children: Differential effects of dose on academic, learning, and social behavior

  1985cited by this paper
• The normalizing effects of methylphenidate on the classroom behavior of ADDH children

  1985cited by this paper
• Young adult outcome of hyperactive children who received long-term stimulant treatment.

  1984cited by this paper
• Effects of age and Ritalin dosage on the mother-child interactions of hyperactive children.

  1984cited by this paper
• Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.

  1984cited by this paper
• Clinical Correlates of Methylphenidate Blood Levels

  1984influential reference
• Distribution of methylphenidate and p-hydroxymethylphenidate in rats.

  1984cited by this paper
• Methylphenidate hydrochloride given with or before breakfast

  1983cited by this paper
• Pharmacokinetics of methylphenidate in man, rat and monkey.

  1983cited by this paper
• Methylphenidate hydrochloride given with or before breakfast: II. Effects on plasma concentration of methylphenidate and ritalinic acid.

  1983cited by this paper
• Methylphenidate hydrochloride given with or before breakfast: I. Behavioral, cognitive, and electrophysiologic effects.

  1983influential reference
• Clinical studies of methylphenidate serum levels in children and adults.

  1982cited by this paper
• Psychopharmacology of attention deficit disorder: pharmacokinetic, neuroendocrine, and behavioral measures following acute and chronic treatment with methylphenidate.

  1982cited by this paper
• Metabolism of methylphenidate in dog and rat.

  1981cited by this paper
• 42 A FOUR-YEAR FOLLOWUP STUDY OF THE EFFECTS OF METHYLPHENIDATE ON THE BEHAVIOR AND ACADEMIC ACHIEVEMENT OF HYPERACTIVE CHILDREN

  1981cited by this paper
• Psychosocial aspects of drug treatment for hyperactivity

  1981cited by this paper
• A four-year follow-up study of the effects of methylphenidate on the behavior and academic achievement of hyperactive children

  1981cited by this paper
• Pharmacokinetics of methylphenidate in hyperkinetic children.

  1979cited by this paper
• Comparison of the effects of the isomers of amphetamine, methylphenidate and deoxypipradrol on the uptake of l-[3H]norepinephrine and [3H]dopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus.

  1979cited by this paper
• The effects of methylphenidate on the mother-child interactions of hyperactive children.

  1979cited by this paper
• Comparison of oral and intravenous methylphenidate

  1978cited by this paper
• Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity.

  1978cited by this paper
• The effect of central nervous system stimulants on tourette syndrome

  1977cited by this paper
• Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behavior.

  1977cited by this paper
• Methylphenidate: A Review

  1976cited by this paper
• A reproducible gas chromatographic mass spectrometric assay for low levels of methylphenidate and ritalinic acid in blood and urine.

  1975cited by this paper
• Effect of long-term treatment of hyperactive children with methylphenidate.

  1975cited by this paper
• Metabolism and disposition of methylphenidate-14C: studies in man and animals.

  1974influential reference
• [Treatment of narcolepsy].

  1965cited by this paper

• Nano-NiCo2O4-catalyzed dehydrogenative direct esterification and amidation of primary alcohols under microwave conditions

  2026cites this paper
• A division of labor in perception-action integration via hierarchical alpha-beta to beta-gamma coupling and local catecholaminergic control

  2026cites this paper
• Therapeutic Reference Ranges for ADHD Drugs in Blood of Children and Adolescents: A Systematic Review by the AGNP TDM-Task Force

  2025cites this paper
• Neurophysiological insights into catecholamine-dependent tDCS modulation of cognitive control

  2025cites this paper
• Methylphenidat ohne klinischen Nutzen

  2025cites this paper
• Medical management of ADHD in adults: part 2

  2025cites this paper
• Current insights into the safety and adverse effects of methylphenidate in children, adolescents, and adults - narrative review

  2025cites this paper
• Acute Administration of 10 mg Methylphenidate on Cognitive Performance and Visual Scanning in Healthy Adults: Randomised, Double‐Blind, Placebo‐Controlled Study

  2025cites this paper
• GABA and Glx levels in cortico-subcortical networks predict catecholaminergic effects on response inhibition

  2025cites this paper
• Methylphenidate (Ritalin) does not improve exam performance in an experimental setting.

  2025cites this paper
• Comparative Bioavailability of Methylphenidate Powder for Prolonged-Release Oral Suspension and Methylphenidate Prolonged-Release Chewable Tablets versus Methylphenidate Immediate-Release Tablets: Phase 1, Single-Dose, Randomised, Crossover Studies in Healthy Adults

  2025cites this paper
• Holistic Management of Adult ADHD with a History of Addiction: Emphasis on Low-Addiction-Risk Psychopharmacotherapy

  2025cites this paper
• Methylphenidate versus placebo for fatigue in patients with advanced cancer: the MePFAC randomised controlled trial.

  2025cites this paper
• The ADME profile of Threo-4-methylmethylphenidate (4-Mmph, 4-MeTMP, CAS: 467468-40-2) as New Psychoactive Substance (NPS): prediction of absorption, distribution, metabolism and excretion parameters using integrated in silico approach for clinical and forensic purposes.

  2025cites this paper
• Bridging ADHD and Metabolic Disorders: Insights into Shared Mechanisms and Clinical Implications

  2025cites this paper
• Methylphenidate Inhibits the Development of Myopia by Altering Dopamine and Norepinephrine Reuptake

  2025cites this paper
• Pharmacogenetic Testing for Predicting Methylphenidate Treatment Outcomes in Childhood Attention Deficit Hyperactivity Disorder in Turkey: Focus on Carboxylesterase 1, Latrophilin‐3, and Catechol‐O‐Methyltransferase

  2025influential citation
• Carbonylation: Unlocking Opportunities for Bioactive Molecule and Pharmaceutical Development

  2025cites this paper
• Endocrine-disrupting chemicals and clinical outcomes in children with attention-deficit/hyperactivity disorder undergoing methylphenidate treatment: a 12-month follow-up study

  2025cites this paper
• Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

  2025cites this paper
• The Price and Quality of Methylphenidate Products.

  2025cites this paper
• Psilocybin’s acute and persistent brain effects: a precision imaging drug trial

  2025cites this paper
• Response Inhibition in Children With ADHD: A Time Domain and Time–Frequency Domain Analysis Study

  2025cites this paper
• Suboptimal decision making and interpersonal problems in ADHD: longitudinal evidence from a laboratory task

  2024cites this paper
• The Effect of Yoga on Basic Cognitive Functions in Children with ADHD: A Three-Month Follow-up Study

  2024cites this paper
• Intranasal Transfersomal Based In Situ Gel for Augmenting Methylphenidate Bioavailability and Brain Delivery: In Vitro and In Vivo Evaluation

  2024cites this paper
• Amphetamine and methylphenidate potential on the recovery from stroke and traumatic brain injury: a review

  2024cites this paper
• Transdermal Drug Delivery Systems (TDDS): Recent Advances and Failure Modes.

  2024cites this paper
• Moderators of training response to a driver inattention training program for teens with ADHD

  2024cites this paper
• Effects of Catecholaminergic and Transcranial Direct Current Stimulation on Response Inhibition

  2024cites this paper
• FROM NEURONS TO BRAIN NETWORKS, PHARMACODYNAMICS OF STIMULANT MEDICATION FOR ADHD.

  2024cites this paper
• Glutamate imbalance in key structure of the default mode network in adults with attention-deficit/hyperactivity disorder

  2024cites this paper
• Fetal alcohol spectrum disorder and attention deficit hyperactivity disorder stimulant trial in children: an N-of-1 pilot trial to compare stimulant to placebo (FASST): protocol

  2024cites this paper
• Recent advancements and various potential applications of transdermal patches

  2024influential citation
• Methylphenidat (MPH) bei tumorassoziierter Fatigue

  2024cites this paper
• Efficacy of Methylphenidate for Internet Gaming Disorder and Internet Addiction in Patients with Attention-Deficit/Hyperactivity Disorder.

  2024cites this paper
• Methylphenidate Versus Placebo for Treating Fatigue in Patients With Advanced Cancer: Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial

  2024cites this paper
• Design, synthesis and anticholinergic properties of novel α-benzyl dopamine, tyramine, and phenethylamine derivatives.

  2024cites this paper
• A comprehensive review on transdermal patches as an efficient approach for the delivery of drug

  2024cites this paper
• Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial

  2024cites this paper
• Methylphenidate differentially alters corticostriatal connectivity after traumatic brain injury

  2024cites this paper
• Recent Advancement of Medical Patch for Transdermal Drug Delivery

  2023cites this paper
• Attention-Deficit/Hyperactivity Disorder Across the Spectrum: From Childhood to Adulthood.

  2023cites this paper
• Effects of Caffeine on Main Symptoms in Children with ADHD: A Systematic Review and Meta-Analysis of Randomized Trials

  2023cites this paper
• Past and current drug repurposing clinical trials to treat cognition in methamphetamine use: a scoping review of pharmacotherapy candidates

  2023cites this paper
• Rising prescription stimulant poisoning in Australia: a retrospective case series

  2023cites this paper
• Efficacy and tolerability of psychostimulants for symptoms of attention-deficit hyperactivity disorder in preschool children: A systematic review and meta-analysis

  2023cites this paper
• High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder

  2023cites this paper
• Methylphenidate modulates motor cortical dynamics and behavior

  2023influential citation
• Effects of multisession cathodal transcranial direct current stimulation with cognitive training on sociocognitive functioning and brain dynamics in ASD: A double-blind, sham-controlled, randomized EEG study.

  2023cites this paper
• Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

  2023cites this paper
• Psychostimulants for Children: Are We Over or Under Dosing?

  2023cites this paper
• Methylphenidate adsorption onto graphene derivatives: theory and experiment

  2022cites this paper
• Plasma concentrations of methylphenidate enantiomers in adults with ADHD and substance use disorder, with focus on high doses and relationship to carboxylesterase activity

  2022cites this paper
• Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate

  2022cites this paper
• A Review of Ocular Complications Associated with Medications Used for Anxiety, Depression, and Stress

  2022cites this paper
• Meta-Analysis of Pharmacological, Nutraceutical and Phytopharmaceutical Interventions for the Treatment of Cancer Related Fatigue

  2022cites this paper
• Characterisation of seven medications approved for attention-deficit/hyperactivity disorder using in vitro models of hepatic metabolism

  2022cites this paper
• What respiratory physicians should know about narcolepsy and other hypersomnias

  2022cites this paper
• Methylphenidate Restores Behavioral and Neuroplasticity Impairments in the Prenatal Nicotine Exposure Mouse Model of ADHD: Evidence for Involvement of AMPA Receptor Subunit Composition and Synaptic Spine Morphology in the Hippocampus

  2022cites this paper
• The Benefits and Limitations of Stimulants in Treating ADHD.

  2022cites this paper
• Physiologically-based pharmacokinetic modeling to predict methylphenidate exposure affected by interplay among carboxylesterase 1 pharmacogenetics, drug-drug interactions, and sex.

  2022cites this paper
• Effectiveness of Pharmacotherapy for Depression after Adult Traumatic Brain Injury: an Umbrella Review

  2022cites this paper
• Trial of Training to Reduce Driver Inattention in Teens with ADHD.

  2022cites this paper
• Innovative approaches in investigating inter-beat intervals: Graph theoretical method suggests altered autonomic functioning in adolescents with ADHD.

  2022cites this paper
• Motor skills in children with specific learning disorder: A controlled study

  2022cites this paper
• OPTO_A_355091 13..25

  2022cites this paper
• Drugs Affecting the Central Nervous System

  2021cites this paper
• Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1–3 and Human Plasma Membrane Monoamine Transporter

  2021cites this paper
• Methylphenidate for Mild Cognitive Impairment: An Exploratory 3-Day, Randomized, Double-Blind, Placebo-Controlled Trial

  2021cites this paper
• Methylphenidate drug adsorption on the pristine magnesium oxide nanotubes; a computational study

  2021cites this paper
• Outcomes of a 12-week ecologically valid observational study of first treatment with methylphenidate in a representative clinical sample of drug naïve children with ADHD

  2021cites this paper
• Effects of methylphenidate on reinforcement learning depend on working memory capacity

  2021cites this paper
• Masked Tardive Dyskinesia in the Coronavirus Disease 2019 Era

  2021cites this paper
• Stability of Methylphenidate under Various pH Conditions in the Presence or Absence of Gut Microbiota

  2021influential citation
• Pharmacological Cognitive Enhancement and Cheapened Achievement: A New Dilemma

  2021cites this paper
• Determination of methamphetamine and methylphenidate in urine by liquid chromatography/time-of-flight mass spectrometry coupled with solid-phase dispersive extraction, and its pharmacokinetic application

  2021cites this paper
• Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review

  2021cites this paper
• Exploration of a novel virtual environment improves memory consolidation in ADHD

  2020cites this paper
• A Single Low-Dose of Methylphenidate Improves Abnormal Visual Field Testing

  2020cites this paper
• Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.

  2020cites this paper
• Chronic Administration of Methylphenidate Induced Degeneration of Spermatogenesis in Adult Male Rats

  2020cites this paper
• Methylphenidate for attention problems in epilepsy patients: Safety and efficacy.

  2020cites this paper
• Stability of Extemporaneously Prepared Preservative-Free Methylphenidate 5 mg/mL Intravenous Solution

  2020cites this paper
• Amphetamine-induced alteration to gaze parameters: A novel conceptual pathway and implications for naturalistic behavior.

  2020cites this paper
• Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomized, crossover, double-blind trial

  2020cites this paper
• pH-dependent spontaneous hydrolysis rather than gut bacterial metabolism reduces levels of the ADHD treatment, Methylphenidate

  2020cites this paper
• Psychotropic drug concentrations and clinical outcomes in children and adolescents: a systematic review

  2020cites this paper
• Is Methylphenidate Beneficial and Safe in Pharmacological Cognitive Enhancement?

  2020cites this paper
• Cognitive Enhancing Drugs in Sport: Current and Future Concerns

  2020cites this paper
• CHRONIC EXPOSURE TO METHYLPHENIDATE-CONTAMINATED WATER ELICITS SOCIAL IMPAIRMENT TO ZEBRAFISH.

  2020cites this paper
• Methylphenidate boosts choices of mental labor over leisure depending on baseline striatal dopamine

  2020cites this paper
• Silica-Functionalized Nano-Graphene Oxide Composite as Potent-Dispersive Solid-Phase Extraction Adsorbent of Methylphenidate from Urine Samples

  2020cites this paper
• Effet de la médication psychostimulante sur l'éveil et les fonctions cognitives suivant un traumatisme crâniocérébral modéré à sévère

  2020cites this paper
• University of Birmingham Catecholaminergic modulation of meta-learning

  2020cites this paper
• Dexmethylphenidate

  2020cites this paper
• Dyskinesia in Treatment-Naive and Stimulant-Treated Children With ADHD

  2020cites this paper
• Methylphenidate boosts choices of mental labor over leisure depending on striatal dopamine synthesis capacity

  2020cites this paper
• Dexmethylphenidate

  2020cites this paper
• Pharmacokinetics of methylphenidate and ritalinic acid in plasma correlations with exhaled breath and oral fluid in healthy volunteers

  2019cites this paper